INTERNATIONAL PATENT: HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO., LTD., 杭州中美华东制药有限公司 FILES APPLICATION FOR "USE OF CORDYCEPS AND PD1 INHIBITOR IN PREPARATION OF DRUG FOR NON-SMALL CELL LUNG CANCER"

GENEVA, July 14 -- HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO., LTD. (Xiangfuqiao, No. 866 Moganshan Road, Gongshu DistrictHangzhou, Zhejiang 310011), 杭州中美华东制药有限公司 (中国浙江省杭州市拱墅区莫干山路866号祥符桥) filed a patent application (PCT/CN2025/077443) for "USE OF CORDYCEPS AND PD1 INHIBITOR IN PREPARATION OF DRUG FOR NON-SMALL CELL LUNG CANCER" on Feb 14, 2025. With publication no. WO/2025/146215, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International...